Metformax

Metformin Hydrochloride, the active ingredient in Metformax, is a biguanide presented as a tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adults, helping to improve glycaemic control when used as part of a comprehensive diabetes treatment plan. The product complies with European Union quality standards and is manufactured under GMP conditions.

GNH USA supplies Metformax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformax (metformin hydrochloride) is used in the antidiabetic drug class to improve glycaemic control in type 2 diabetes.

- Type 2 diabetes mellitus: lowers blood glucose levels and improves insulin sensitivity. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes. - Polycystic ovary syndrome (off‑label): helps reduce insulin resistance and may improve menstrual regularity.

Metformax may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic complication. - Severe hypoglycaemia: usually when combined with insulin or sulfonylureas. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: elevated liver enzymes in rare cases. - Skin rash or hypersensitivity: occasional allergic reactions.

Before initiating Metformax, several safety considerations should be reviewed.

- Renal function: assess eGFR and avoid use in severe renal impairment. - Hepatic function: monitor liver enzymes in patients with liver disease. - Lactic acidosis risk: discontinue during acute illness, surgery, or hypoxia. - Pregnancy: use only if potential benefit justifies potential risk to the fetus. - Alcohol intake: limit consumption to reduce lactic acidosis risk. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Metformax can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure. - Cimetidine: can increase metformin plasma concentrations. - Excessive alcohol: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors: monitor renal function and potassium levels.